The Multibillion-Dollar Business of Losing

GLP-1 drugs are driving a seismic shift in health care...

There's No Match for U.S. Innovation

Our economy will continue to dominate for years to come.

The Antidote to Our Least-Favorite Acronym

While this framework was designed for war, it's also a powerful weapon in the battle against misleading GAAP metrics...

Ford's EV Gamble Isn't Looking Too Hot

With consumers pulling back on big-ticket purchases, this heavy investment could turn into a heavy burden...

This Fast-Food Giant Is Ready for a New Playbook

Wendy's has been unsuccessfully playing catch-up with its peers since the Great Recession...

The Asset-Manager Arms Race Is Heating Up

Despite being a leader in many asset classes, BlackRock has fallen behind in private credit...